Approval · Notice of Compliance 35397 · 2025
IBUPROFEN CAPLETS: Notice of Compliance 35397
Issued May 22, 2025
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 35397
- Date
- May 22, 2025
- Company
- Vita Health Products Inc.Winnipeg, Manitoba, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Other
- Reason
- Update to private label brand mockups to comply with PLL
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| IBUPROFEN CAPLETS | Not yet assigned | — |
| IBUPROFEN TABLETS | Not yet assigned | — |
Medicinal ingredients
- IBUPROFEN 200 MG per TAB